Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010

Jessica Ing1, Edward O Mason, Sheldon L Kaplan

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Insights

Nontypeable Streptococcus pneumoniae isolates were re-evaluated. Most were confirmed pneumococci, with molecular methods like MLST proving crucial for accurate identification and differentiation from other Streptococcus species.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Streptococcus pneumoniae causes severe childhood infections.
  • Traditional identification methods (optochin, bile solubility, Quellung) can be unreliable for some pneumococcal strains.
  • Nontypeable pneumococci present diagnostic challenges.

Purpose of the Study:

  • To re-characterize isolates previously labeled as nontypeable pneumococci.
  • To determine the accuracy of standard identification methods versus molecular techniques.
  • To differentiate true pneumococci from other Streptococcus species.

Main Methods:

  • Re-testing with expanded Quellung antisera, optochin susceptibility, and bile solubility.
  • Automated Vitek 2 identification.
  • Molecular analyses including PCR for psaA and ply genes, multilocus sequence typing (MLST), 16S rRNA sequencing, and pyrosequencing.

Main Results:

  • 73% of isolates were confirmed as typable pneumococci.
  • Three isolates were nontypeable due to autoagglutination but confirmed as pneumococci by MLST.
  • Eleven isolates were optochin resistant; molecular methods distinguished pneumococci from other Streptococcus species, with psaA and MLST being key differentiators.

Conclusions:

  • Few isolates were truly nontypeable by Quellung reaction.
  • MLST and psaA gene detection are valuable for distinguishing atypical pneumococci.
  • Accurate identification is essential for understanding pneumococcal disease epidemiology and treatment.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...